Diabetes drug rosiglitazone linked to higher heart failure risk
Diabetes medications (rosiglitazone – Avandia) in same class carry different risks of heart failure, death – Older adults who take the diabetes medication rosiglitazone appear to have a higher risk of death and heart failure than those taking the related medication pioglitazone, according to a report in the November 24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.